Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.

MLA

Isonishi, Ayami, et al. “Poor Responder to Plasma Exchange Therapy in Acquired Thrombotic Thrombocytopenic Purpura Is Associated with ADAMTS13 Inhibitor Boosting: Visualization of an ADAMTS13 Inhibitor Complex and Its Proteolytic Clearance from Plasma.” Transfusion, vol. 55, no. 10, Oct. 2015, pp. 2321–30. EBSCOhost, https://doi.org/10.1111/trf.13182.

APA

Isonishi, A., Bennett, C. L., Plaimauer, B., Scheiflinger, F., Matsumoto, M., & Fujimura, Y. (2015). Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion, 55(10), 2321–2330. https://doi.org/10.1111/trf.13182

Chicago

Isonishi, Ayami, Charles L Bennett, Barbara Plaimauer, Friedrich Scheiflinger, Masanori Matsumoto, and Yoshihiro Fujimura. 2015. “Poor Responder to Plasma Exchange Therapy in Acquired Thrombotic Thrombocytopenic Purpura Is Associated with ADAMTS13 Inhibitor Boosting: Visualization of an ADAMTS13 Inhibitor Complex and Its Proteolytic Clearance from Plasma.” Transfusion 55 (10): 2321–30. doi:10.1111/trf.13182.